Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Rubius Therapeutics, Inc. (RUBY)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.093.944.10.0
            Revenue growth     -100.0%113.0%  
Cost of goods sold  0.00.00.00.00.00.00.0
Gross profit  0.00.00.00.093.944.10.0
            Gross margin      100.0%100.0% 
Selling, general and administrative   [+]30.853.050.357.239.922.02.4
Research and development  96.4141.6116.1112.451.821.28.4
Other operating expenses      93.944.1 
EBITDA   [+]-121.0-186.9-160.8-166.6-90.4-42.8-10.7
            EBITDA margin      -96.3%-97.2% 
Depreciation and amortization  6.37.75.73.01.30.40.1
EBIT   [+]-127.2-194.6-166.4-169.6-91.7-43.3-10.9
            EBIT margin      -97.7%-98.2% 
Non-recurring items  51.2      
Interest expense, net   [+]3.06.32.4-5.4-4.6-0.30.1
Other income (expense), net   [+]1.84.41.10.7-2.1-0.90.0
Pre-tax income  -179.7-196.5-167.7-163.5-89.2-43.8-11.0
Income taxes  0.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -179.7-196.5-167.7-163.5-89.2-44.5-11.8
            Net margin      -95.0%-101.0% 
   
Basic EPS   [+]($1.99)($2.23)($2.08)($2.08)($2.27)($5.55)($1.63)
Diluted EPS   [+]($1.99)($2.23)($2.08)($2.08)($2.27)($5.55)($1.63)
   
Shares outstanding (basic)   [+]90.388.080.678.739.38.07.2
Shares outstanding (diluted)   [+]90.388.080.678.739.38.07.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy